Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion type Assertion NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_head.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion description "[Among other clinical and genetic factors, polymorphisms of CYP2B6 genes that interfere with cyclophosphamide metabolism were associated with OM (recipient CYP2B6(*)4; P=0.0067), HC (recipient CYP2B6(*)2; P=0.03) and VOD (donor CYP2B6(*)6; P=0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion evidence source_evidence_literature NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion SIO_000772 19005482 NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion wasDerivedFrom befree-2016 NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.
- NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_assertion wasGeneratedBy ECO_0000203 NP703069.RAEEVUTo0Fnb1-4_xbQZAkL-MNJXMNsy4FzG3NRvzRq1k130_provenance.